Get certified with Sherringford’s training programs: Medical Assistant, Surgical Assistant, and CPR/BLS by AHA. Build skills for a successful career. Our Services Basic Life Support (BLS)/CPR training The Basic Life Support (BLS) course is certified by the American Heart Association (AHA). Info Medical Assistant Certification National MA Certification by accredited organization in Florida and other US states. Info Surgical Assistant (SA) Certification Accredited by the American Board of Surgical Assistant (ABSA). Info Unlock your potential, grow your opportunities If you are looking for personal contact and detailed information about our services, we invite you to contact us. Our dedicated team is ready to answer your questions, guide you through our offerings, and connect you to the resources you need. Don't hesitate to contact us, your journey to excellence in healthcare education is just a call away. Schedule a 5 min consultation Or you can contact us by this form ↠ Ask for anything Name Email* Message* Submit Sherringford We designed Sherringford.org to be more than just an educational resource; it's a platform intended to bring a refreshing twist to your daily professional life. Explore Main Pages Home About us Search Pricing Store Points Knowledge Library Blog News Courses Services Community Infotainment MH Colaboration Advertise with us Suggestions Work with us Publish on our blog Publish mentor availability Find a mentor Donations Comply Private Policy Disclosure Terms and Conditions Do Not Sell My Personal Information

Earn rewards as you learn! Our Loyalty page shows you how to accumulate points and redeem them for exclusive benefits. Start maximizing your rewards today! Challenge Points Earn points and turn them into rewards Become a Member 01 Sign Up Sign up as a member to start enjoying the loyalty program 02 Earn Points Blog comment every 3 hours Get 3 points Complete a Course Get 10 points Complete any course step Get 3 points Forum comment Get 2 points Get a membership Get 2 points for every $1 spent Order a plan Get 1 point for every $1 spent Post in Forum every 8 hours Get 8 points Redeem points Get 5 points Sign in daily Get 2 points Sign up to the site Get 10 points 03 Redeem Rewards Flexible reward 100 Points = $1 discount Sherringford We designed Sherringford.org to be more than just an educational resource; it's a platform intended to bring a refreshing twist to your daily professional life. Explore Main Pages Home About us Search Pricing Store Points Knowledge Library Blog News Courses Services Community Infotainment MH Colaboration Advertise with us Suggestions Work with us Publish on our blog Publish mentor availability Find a mentor Donations Comply Private Policy Disclosure Terms and Conditions Do Not Sell My Personal Information

We can’t find the page you’re looking for This page doesn’t exist. Go to Home and keep exploring. Go to Home

Video Info Health experts respond to Trump's claims linking autism to acetaminophen President Trump tied the use of acetaminophen during pregnancy to autism and made several other claims about vaccines. William Brangham discussed those claims and the concerns about what the president said with Alycia Halladay of the Autism Science Foundation and Jennifer Nuzzo of Brown University’s School of Public Health. Watch PBS News for daily, breaking and live news, plus special coverage. We are home to PBS News Hour, ranked the most credible and objective TV news show. Comment comments debug Comments Write a comment Write a comment Share Your Thoughts Be the first to write a comment. GLP-1 Agonists Redefine Cardiac Care Alkermes and Takeda in Narcolepsy Treatment Novartis Invests Against Heart Disease A New Pathway for IMGs to Practice in the U.S. Respond to Trump's claims about acetaminophen 'Nightmare bacteria' cases Caution after measles virus detected in Oswego Experimental gene therapy slows Huntington's disease GLP-1 Agonists Redefine Cardiac Care Alkermes and Takeda in Narcolepsy Treatment Novartis Invests Against Heart Disease A New Pathway for IMGs to Practice in the U.S. Respond to Trump's claims about acetaminophen 'Nightmare bacteria' cases Caution after measles virus detected in Oswego Experimental gene therapy slows Huntington's disease GLP-1 Agonists Redefine Cardiac Care Alkermes and Takeda in Narcolepsy Treatment Novartis Invests Against Heart Disease A New Pathway for IMGs to Practice in the U.S. Respond to Trump's claims about acetaminophen 'Nightmare bacteria' cases Caution after measles virus detected in Oswego Experimental gene therapy slows Huntington's disease GLP-1 Agonists Redefine Cardiac Care Alkermes and Takeda in Narcolepsy Treatment Novartis Invests Against Heart Disease A New Pathway for IMGs to Practice in the U.S. Respond to Trump's claims about acetaminophen 'Nightmare bacteria' cases Caution after measles virus detected in Oswego Experimental gene therapy slows Huntington's disease Go Return Go

Video Info North Carolina's Game-Changing Senate Bill 336: A New Pathway for IMGs to Practice in the U.S. Forget everything you thought you knew about the path to licensure for International Medical Graduates (IMGs) in the United States. North Carolina has rolled out a groundbreaking new state bill, Senate Bill 336, that could revolutionize the process. This isn't clickbait. The state is creating a new avenue that could allow eligible IMGs to obtain a license with no USMLE exams and no U.S. residency required. Comment comments debug Comments Write a comment Write a comment Share Your Thoughts Be the first to write a comment. GLP-1 Agonists Redefine Cardiac Care Alkermes and Takeda in Narcolepsy Treatment Novartis Invests Against Heart Disease A New Pathway for IMGs to Practice in the U.S. Respond to Trump's claims about acetaminophen 'Nightmare bacteria' cases Caution after measles virus detected in Oswego Experimental gene therapy slows Huntington's disease GLP-1 Agonists Redefine Cardiac Care Alkermes and Takeda in Narcolepsy Treatment Novartis Invests Against Heart Disease A New Pathway for IMGs to Practice in the U.S. Respond to Trump's claims about acetaminophen 'Nightmare bacteria' cases Caution after measles virus detected in Oswego Experimental gene therapy slows Huntington's disease GLP-1 Agonists Redefine Cardiac Care Alkermes and Takeda in Narcolepsy Treatment Novartis Invests Against Heart Disease A New Pathway for IMGs to Practice in the U.S. Respond to Trump's claims about acetaminophen 'Nightmare bacteria' cases Caution after measles virus detected in Oswego Experimental gene therapy slows Huntington's disease GLP-1 Agonists Redefine Cardiac Care Alkermes and Takeda in Narcolepsy Treatment Novartis Invests Against Heart Disease A New Pathway for IMGs to Practice in the U.S. Respond to Trump's claims about acetaminophen 'Nightmare bacteria' cases Caution after measles virus detected in Oswego Experimental gene therapy slows Huntington's disease Go Return Go

Video Info Novartis Invests Heavily Against Inflammation in Heart Disease Novartis acquires Tourmaline Bio for $1.4 billion, focusing on pacibekitug, a drug that combats inflammation in heart disease like ASCVD, promising significant advancements in cardiovascular treatment. Comment comments debug Comments Write a comment Write a comment Share Your Thoughts Be the first to write a comment. GLP-1 Agonists Redefine Cardiac Care Alkermes and Takeda in Narcolepsy Treatment Novartis Invests Against Heart Disease A New Pathway for IMGs to Practice in the U.S. Respond to Trump's claims about acetaminophen 'Nightmare bacteria' cases Caution after measles virus detected in Oswego Experimental gene therapy slows Huntington's disease GLP-1 Agonists Redefine Cardiac Care Alkermes and Takeda in Narcolepsy Treatment Novartis Invests Against Heart Disease A New Pathway for IMGs to Practice in the U.S. Respond to Trump's claims about acetaminophen 'Nightmare bacteria' cases Caution after measles virus detected in Oswego Experimental gene therapy slows Huntington's disease GLP-1 Agonists Redefine Cardiac Care Alkermes and Takeda in Narcolepsy Treatment Novartis Invests Against Heart Disease A New Pathway for IMGs to Practice in the U.S. Respond to Trump's claims about acetaminophen 'Nightmare bacteria' cases Caution after measles virus detected in Oswego Experimental gene therapy slows Huntington's disease GLP-1 Agonists Redefine Cardiac Care Alkermes and Takeda in Narcolepsy Treatment Novartis Invests Against Heart Disease A New Pathway for IMGs to Practice in the U.S. Respond to Trump's claims about acetaminophen 'Nightmare bacteria' cases Caution after measles virus detected in Oswego Experimental gene therapy slows Huntington's disease Go Return Go

Video Info Alkermes and Takeda are Leading a Revolution in Narcolepsy Treatment Alkermes' Alixorexton and Takeda's Oveporexton are leading a revolution in narcolepsy treatment, with promising results in Phase 2 and 3 trials. These OX2R receptor agonists offer hope for patients with narcolepsy type 1, improving wakefulness and reducing cataplexy. Comment comments debug Comments Write a comment Write a comment Share Your Thoughts Be the first to write a comment. GLP-1 Agonists Redefine Cardiac Care Alkermes and Takeda in Narcolepsy Treatment Novartis Invests Against Heart Disease A New Pathway for IMGs to Practice in the U.S. Respond to Trump's claims about acetaminophen 'Nightmare bacteria' cases Caution after measles virus detected in Oswego Experimental gene therapy slows Huntington's disease GLP-1 Agonists Redefine Cardiac Care Alkermes and Takeda in Narcolepsy Treatment Novartis Invests Against Heart Disease A New Pathway for IMGs to Practice in the U.S. Respond to Trump's claims about acetaminophen 'Nightmare bacteria' cases Caution after measles virus detected in Oswego Experimental gene therapy slows Huntington's disease GLP-1 Agonists Redefine Cardiac Care Alkermes and Takeda in Narcolepsy Treatment Novartis Invests Against Heart Disease A New Pathway for IMGs to Practice in the U.S. Respond to Trump's claims about acetaminophen 'Nightmare bacteria' cases Caution after measles virus detected in Oswego Experimental gene therapy slows Huntington's disease GLP-1 Agonists Redefine Cardiac Care Alkermes and Takeda in Narcolepsy Treatment Novartis Invests Against Heart Disease A New Pathway for IMGs to Practice in the U.S. Respond to Trump's claims about acetaminophen 'Nightmare bacteria' cases Caution after measles virus detected in Oswego Experimental gene therapy slows Huntington's disease Go Return Go

Video Info It’s an early warning system” Health commissioner urges caution after measles virus detected in Oswego The New York State Department of Health has issued an alert after traces of the measles virus were detected in wastewater from a treatment plant serving Oswego and nearby areas. Comment comments debug Comments Write a comment Write a comment Share Your Thoughts Be the first to write a comment. GLP-1 Agonists Redefine Cardiac Care Alkermes and Takeda in Narcolepsy Treatment Novartis Invests Against Heart Disease A New Pathway for IMGs to Practice in the U.S. Respond to Trump's claims about acetaminophen 'Nightmare bacteria' cases Caution after measles virus detected in Oswego Experimental gene therapy slows Huntington's disease GLP-1 Agonists Redefine Cardiac Care Alkermes and Takeda in Narcolepsy Treatment Novartis Invests Against Heart Disease A New Pathway for IMGs to Practice in the U.S. Respond to Trump's claims about acetaminophen 'Nightmare bacteria' cases Caution after measles virus detected in Oswego Experimental gene therapy slows Huntington's disease GLP-1 Agonists Redefine Cardiac Care Alkermes and Takeda in Narcolepsy Treatment Novartis Invests Against Heart Disease A New Pathway for IMGs to Practice in the U.S. Respond to Trump's claims about acetaminophen 'Nightmare bacteria' cases Caution after measles virus detected in Oswego Experimental gene therapy slows Huntington's disease GLP-1 Agonists Redefine Cardiac Care Alkermes and Takeda in Narcolepsy Treatment Novartis Invests Against Heart Disease A New Pathway for IMGs to Practice in the U.S. Respond to Trump's claims about acetaminophen 'Nightmare bacteria' cases Caution after measles virus detected in Oswego Experimental gene therapy slows Huntington's disease Go Return Go

Video Info 'Nightmare bacteria' cases are increasing in the US Government scientists say infection rates from drug-resistant “nightmare bacteria” have been increasing dramatically. Comment comments debug Comments Write a comment Write a comment Share Your Thoughts Be the first to write a comment. GLP-1 Agonists Redefine Cardiac Care Alkermes and Takeda in Narcolepsy Treatment Novartis Invests Against Heart Disease A New Pathway for IMGs to Practice in the U.S. Respond to Trump's claims about acetaminophen 'Nightmare bacteria' cases Caution after measles virus detected in Oswego Experimental gene therapy slows Huntington's disease GLP-1 Agonists Redefine Cardiac Care Alkermes and Takeda in Narcolepsy Treatment Novartis Invests Against Heart Disease A New Pathway for IMGs to Practice in the U.S. Respond to Trump's claims about acetaminophen 'Nightmare bacteria' cases Caution after measles virus detected in Oswego Experimental gene therapy slows Huntington's disease GLP-1 Agonists Redefine Cardiac Care Alkermes and Takeda in Narcolepsy Treatment Novartis Invests Against Heart Disease A New Pathway for IMGs to Practice in the U.S. Respond to Trump's claims about acetaminophen 'Nightmare bacteria' cases Caution after measles virus detected in Oswego Experimental gene therapy slows Huntington's disease GLP-1 Agonists Redefine Cardiac Care Alkermes and Takeda in Narcolepsy Treatment Novartis Invests Against Heart Disease A New Pathway for IMGs to Practice in the U.S. Respond to Trump's claims about acetaminophen 'Nightmare bacteria' cases Caution after measles virus detected in Oswego Experimental gene therapy slows Huntington's disease Go Return Go

Video Info Experimental gene therapy slows Huntington's disease in trial | REUTERS UniQure's experimental gene therapy for Huntington's disease slowed progression of the brain disorder by 75% in an early-to-mid stage study. Comment comments debug Comments Write a comment Write a comment Share Your Thoughts Be the first to write a comment. GLP-1 Agonists Redefine Cardiac Care Alkermes and Takeda in Narcolepsy Treatment Novartis Invests Against Heart Disease A New Pathway for IMGs to Practice in the U.S. Respond to Trump's claims about acetaminophen 'Nightmare bacteria' cases Caution after measles virus detected in Oswego Experimental gene therapy slows Huntington's disease GLP-1 Agonists Redefine Cardiac Care Alkermes and Takeda in Narcolepsy Treatment Novartis Invests Against Heart Disease A New Pathway for IMGs to Practice in the U.S. Respond to Trump's claims about acetaminophen 'Nightmare bacteria' cases Caution after measles virus detected in Oswego Experimental gene therapy slows Huntington's disease GLP-1 Agonists Redefine Cardiac Care Alkermes and Takeda in Narcolepsy Treatment Novartis Invests Against Heart Disease A New Pathway for IMGs to Practice in the U.S. Respond to Trump's claims about acetaminophen 'Nightmare bacteria' cases Caution after measles virus detected in Oswego Experimental gene therapy slows Huntington's disease GLP-1 Agonists Redefine Cardiac Care Alkermes and Takeda in Narcolepsy Treatment Novartis Invests Against Heart Disease A New Pathway for IMGs to Practice in the U.S. Respond to Trump's claims about acetaminophen 'Nightmare bacteria' cases Caution after measles virus detected in Oswego Experimental gene therapy slows Huntington's disease Go Return Go